Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.7 |